Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year?
https://www.zacks.com/stock/news/2233203/is-adicet-bio-acet-stock-outpacing-its-medical-peers-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2233203
Feb 28, 2024 - Here is how Adicet Bio, Inc. (ACET) and Adma Biologics (ADMA) have performed compared to their sector so far this year.
0
Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates
https://www.zacks.com/stock/news/2236964/generation-bio-co-gbio-reports-q4-loss-lags-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236964
Mar 06, 2024 - Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -29.27% and 5.64%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Should You Buy Gossamer Bio (GOSS) After Golden Cross?
https://www.zacks.com/stock/news/2237343/should-you-buy-gossamer-bio-goss-after-golden-cross?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2237343
Mar 07, 2024 - Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
0
Entera Bio GAAP EPS of -$0.31 beats by $0.01
https://seekingalpha.com/news/4077759-entera-bio-gaap-eps-of-0_31-beats-0_01?source=feed_tag_israel
Mar 08, 2024 - Entera Bio beats expectations with FY 2023 GAAP EPS of -$0.31.
0
Oncology drug developer Boundless Bio files for $100M IPO
https://seekingalpha.com/news/4077787-oncology-drug-developer-boundless-bio-files-for-100m-ipo?source=feed_sector_healthcare
Mar 08, 2024 - Boundless Bio (BOLD), a developer of ecDNA-directed oncology therapeutics, has filed for a proposed $100M initial public offering. Read more here.
0
Nuvation Bio Inc. (NUVB) Is Up 25.28% in One Week: What You Should Know
https://www.zacks.com/stock/news/2238205/nuvation-bio-inc-nuvb-is-up-25-28-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2238205
Mar 08, 2024 - Does Nuvation Bio Inc. (NUVB) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Boundless Bio Starts $100 Million U.S. IPO Plan
https://seekingalpha.com/article/4677702-boundless-bio-starts-100-million-us-ipo-plan?source=feed_tag_ipo_analysis
Mar 12, 2024 - Boundless Bio filed for $a 100M IPO to develop DNA treatments for cancer, and its lead candidate is in Phase 1 trials. Click here to learn more about BOLD.
0
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
https://www.zacks.com/stock/news/2241353/are-medical-stocks-lagging-adicet-bio-acet-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2241353
Mar 15, 2024 - Here is how Adicet Bio, Inc. (ACET) and Adma Biologics (ADMA) have performed compared to their sector so far this year.
0
2seventy bio appoints Eli Casdin and Charles Newton to its board of directors
https://seekingalpha.com/news/4081841-2seventy-bio-appoints-eli-casdin-and-charles-newton-to-its-board-of-directors?source=feed_sector_healthcare
Mar 20, 2024 - 2seventy bio (TSVT) announces the appointment of Eli Casdin and Charles Newton to its board of directors.
0
Bayer-backed Boundless Bio sets terms for $100M IPO
https://seekingalpha.com/news/4082227-bayer-back-boundless-bio-sets-terms-for-100m-ipo?source=feed_sector_healthcare
Mar 21, 2024 - Bayer-backed Boundless Bio (BOLD), an oncology drug developer, has set terms for a proposed $100M initial public offering. Read more here.
0
Page 1>